San Jose, California (PRWEB) January 07, 2014
Follow us on LinkedIn – Growing instances of drug failures in late stage clinical trials is throwing the spotlight on biosimulation. Defined as the use of computers to simulate biological processes, biosimulation is growing in popularity with pharmaceutical companies stepping up investments in this space. Key factors driving adoption of biosimulation tools and solutions among drug developers include growing regulatory, competitive, and budgetary pressures. Broader adoption of pharmacokinetic, and pharmacodynamic modelling in pre-clinical drug discovery is also expected to drive growth in the market.
The trend report titled “Biosimulation” announced by Global Industry Analysts Inc., is a focused research paper which provides cursory insights into the technology, its evolution, applications, future prospects, and corporate initiatives of key companies worldwide. The report provides global market estimates and projections for Biosimulation in US dollars for the years 2012 through 2017. The report also offers coverage on key companies such as Accelrys Inc., Advanced Chemistry Development Inc., Chemical Computing Group Inc., Entelos Inc., GNS Healthcare, In Silico Biosciences Inc., Insilico Biotechnology AG, Molecular Knowledge Systems Inc., Novo Nordisk A/S, Rhenovia Pharma SAS, Simulations Plus Inc., Synergix Ltd., and TheraSim, among others.
For more details about this trend report, please visit http://www.strategyr.com/TrendReport.asp?code=146055.
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/
Read the full story at http://www.prweb.com/releases/biosimulation_market/drug_development/prweb11467659.htm.
Copyright©2012 Vocus, Inc.
All rights reserved